This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Close

Theramex News

14 May 2021

Theramex to host Menopause Post-Pandemic Webinar for Healthcare Professionals – 19th May, 7pm

As healthcare services begin to return to the ‘new-normal’ from the Covid-19 pandemic, there is a need to re-focus on menopause to ensure women receive the care and support they need to manage their perimenopausal symptoms and menopause journey.

This expert led webinar will explore the current situation with delivering menopause care during and beyond the Covid-19 pandemic. The speakers, Dr Anne Connolly & Dr Paula Briggs, will discuss how we effectively manage menopause using case studies to bring the subject to life with both a practical and clinical approach.

If you are a healthcare professional wishing to join, register for the event here:

10 June 2021

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antiresorptive treatment for osteoporosis, a biosimilar of reference medicine Prolia®, in Europe, the UK, Switzerland, and Australia

Read more

13 May 2021

Theramex response to ‘Davina McCall: Sex, Myths and The Menopause’ documentary

Read more